Table 1 Demographic, laboratory, clinical characteristics, and duration of medication use in 4,253 newly diagnosed type 2 diabetes patients
Variables | Time | |
|---|---|---|
Diagnosis time | Mean in cohorts exams | |
Democracy Characteristics (4,068 newly diagnosed DM) | ||
Age (year) | 49.8 ± 1.3 (40,79) | 60.2 ± 0.85 (40,88) |
Sex | ||
• Male • Female | 1,883(46.3%) 2,185(53.7%) | - |
Education level (Year) | ||
• Illiterate • < 8 • 8–16 • > 16 | 346(8.5%) 956(23.5%) 1,851(45.5%) 915(22.5%) | - |
Smoke (yes) | 1,997(49.1%) | - |
Race | ||
• White • Black • Other | 2,964 (69.7%) 846(19.9%) 443(10.4%) | - |
Marital status(n) | ||
• Married • Unmarried • Divorced or widow | 3,633 (89.3%) 199 (4.9%) 236(5.8%) | - |
Aspirin use | 3,551(83.8%) | - |
Statin use | 1,042 (24.5%) | - |
Anti-Hypertensive Drugs | 3,117(73.3%) | |
BMI(kg/m2) | 28.8 ± 0.32 | 27.9 ± 0.14 |
Waist(cm) | 97.09 ± 0.23 | 101.2 ± 0.44 |
Physical activity(m/w) | 69.4 ± 0.37 | 75.2 ± 0.26 |
Clinical & Laboratory finding | ||
FBS (mg/dl) | 160.6 ± 1.59 | 148.6 ± 2.1 |
Cholesterol(mg/dl) | 225.80 ± 1.3 | 198.4 ± 0.89 |
HDL(mg/dl) | 58.3 ± 1.7 | 50.07 ± 0.45 |
Triglyceride(mg/dl) | 177.5 ± 1.85 | 161.8 ± 1.7 |
Creatinine(mg/dl) | 1.02 ± 0.007 | 1.06 ± 0.005 |
Systolic blood pressure (mmHg) | 136.7 ± 1.4 | 131.2 ± 1.5 |
Diastolic blood pressure (mmHg) | 82.2 ± 0.75 | 79.9 ± 0.63 |
Mean Medication time in years (range) | ||
Metformin | 6.25 ± 0.41 | (0.6, 14.2) |
Sulfonylurea | 5.86 ± 0.62 | (0.7,11.4) |
Sulfonylurea + Metformin | 4.88 ± 0.8 | (0.6,13.5) |
Aspirin use | 13.9 ± 2.3 | (0.7,18.7) |
Anti-Hypertensive Drugs | 14.5 ± 21.99 | (0.9,20.9) |
Statin | 10.11 ± 2.8 | (0.6,17.9) |